235 related articles for article (PubMed ID: 24863849)
1. In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe.
Shimizu Y; Temma T; Hara I; Makino A; Kondo N; Ozeki E; Ono M; Saji H
Cancer Sci; 2014 Aug; 105(8):1056-62. PubMed ID: 24863849
[TBL] [Abstract][Full Text] [Related]
2. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
Shimizu Y; Temma T; Sano K; Ono M; Saji H
Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
[TBL] [Abstract][Full Text] [Related]
3. Micelle-based activatable probe for in vivo near-infrared optical imaging of cancer biomolecules.
Shimizu Y; Temma T; Hara I; Makino A; Yamahara R; Ozeki E; Ono M; Saji H
Nanomedicine; 2014 Jan; 10(1):187-95. PubMed ID: 23811292
[TBL] [Abstract][Full Text] [Related]
4. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers.
Kondo N; Temma T; Shimizu Y; Watanabe H; Higano K; Takagi Y; Ono M; Saji H
Cancer Sci; 2013 Apr; 104(4):495-501. PubMed ID: 23305265
[TBL] [Abstract][Full Text] [Related]
5. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
6. Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors.
Temma T; Sano K; Kuge Y; Kamihashi J; Takai N; Ogawa Y; Saji H
Biol Pharm Bull; 2009 Jul; 32(7):1272-7. PubMed ID: 19571397
[TBL] [Abstract][Full Text] [Related]
7. Molecular recognition of proteolytic activity in metastatic cancer cells using fluorogenic gold nanoprobes.
Hong Y; Ku M; Heo D; Hwang S; Lee E; Park J; Choi J; Lee HJ; Seo M; Lee EJ; Yook JI; Haam S; Huh YM; Yoon DS; Suh JS; Yang J
Biosens Bioelectron; 2014 Jul; 57():171-8. PubMed ID: 24583688
[TBL] [Abstract][Full Text] [Related]
8. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
Kondo N; Temma T; Shimizu Y; Ono M; Saji H
Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
[TBL] [Abstract][Full Text] [Related]
10. Ratiometric Imaging of MMP-2 Activity Facilitates Tumor Detection Using Activatable Near-Infrared Fluorescent Semiconducting Polymer Nanoparticles.
Zeng W; Wu L; Sun Y; Wang Y; Wang J; Ye D
Small; 2021 Sep; 17(36):e2101924. PubMed ID: 34309199
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Li L; Du Y; Chen X; Tian J
Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
[TBL] [Abstract][Full Text] [Related]
12. In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.
Zhu L; Zhang F; Ma Y; Liu G; Kim K; Fang X; Lee S; Chen X
Mol Pharm; 2011 Dec; 8(6):2331-8. PubMed ID: 22014151
[TBL] [Abstract][Full Text] [Related]
13. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
Waschkau B; Faust A; Schäfers M; Bremer C
Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
[TBL] [Abstract][Full Text] [Related]
14. MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging.
Ji X; Xie S; Jiao Y; Zhang X; Sun D; Yang VC; Wang M; He H; Sun L
Biomater Sci; 2020 Apr; 8(8):2308-2317. PubMed ID: 32186291
[TBL] [Abstract][Full Text] [Related]
15. High-affinity peptide against MT1-MMP for in vivo tumor imaging.
Zhu L; Wang H; Wang L; Wang Y; Jiang K; Li C; Ma Q; Gao S; Wang L; Li W; Cai M; Wang H; Niu G; Lee S; Yang W; Fang X; Chen X
J Control Release; 2011 Mar; 150(3):248-55. PubMed ID: 21295090
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of membrane type-1 matrix metalloproteinase relevant to tumor malignancy with a pre-targeting method.
Sano K; Temma T; Kuge Y; Kudo T; Kamihashi J; Zhao S; Saji H
Biol Pharm Bull; 2010; 33(9):1589-95. PubMed ID: 20823579
[TBL] [Abstract][Full Text] [Related]
17. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
18. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
[TBL] [Abstract][Full Text] [Related]
19. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
[TBL] [Abstract][Full Text] [Related]
20. Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.
Zhu L; Ma Y; Kiesewetter DO; Wang Y; Lang L; Lee S; Niu G; Chen X
ACS Chem Biol; 2014 Feb; 9(2):510-6. PubMed ID: 24266806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
